Kristian Jensen, Senior Global Medical Director at GSK, shared on LinkedIn:
“Exciting opportunity for oncology leaders with a passion for lung cancer.
With ESMO just around the corner and another exciting year of lung cancer data ahead, it’s an incredibly energizing time to be working in oncology.
I’m fortunate to work with a fantastic team at GSK, and I’m delighted that we’re continuing to grow our Global Lung Cancer Medical Affairs organization with an additional Global Medical Director position.
As our portfolio and ambitions continue to expand, we’re looking for a medical affairs leader who is passionate about science, strategy, and ultimately improving outcomes for patients living with lung cancer.
If this sounds like you, or someone in your network, I’d love to hear from you. And if you’re attending ESMO, please feel free to connect and say hello.
Looking forward to the discussions, collaborations, and data that lie ahead.”
GSK is a global biopharmaceutical company focused on bringing together science, technology, and talent to get ahead of disease. Its goal is to positively impact the health of 2.5 billion people by the end of the decade while building a successful, growing company where people can thrive. GSK works to prevent and treat diseases through innovation in specialty medicines and vaccines. The company focuses on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases, with the aim of improving health on a large scale.
Read more articles about GSK on OncoDaily.